Your browser is no longer supported. Please, upgrade your browser.
ESRX Express Scripts Holding Company daily Stock Chart
Express Scripts Holding Company
IndexS&P 500 P/E12.87 EPS (ttm)5.44 Insider Own0.25% Shs Outstand610.10M Perf Week2.28%
Market Cap42.69B Forward P/E9.18 EPS next Y7.62 Insider Trans-2.36% Shs Float610.10M Perf Month-3.42%
Income3.40B PEG1.00 EPS next Q1.33 Inst Own87.60% Short Float3.43% Perf Quarter-8.12%
Sales100.29B P/S0.43 EPS this Y51.40% Inst Trans-2.38% Short Ratio5.11 Perf Half Y-8.68%
Book/sh26.66 P/B2.62 EPS next Y9.95% ROA6.70% Target Price80.67 Perf Year2.88%
Cash/sh5.04 P/C13.87 EPS next 5Y12.89% ROE21.90% 52W Range64.46 - 80.02 Perf YTD1.72%
Dividend- P/FCF9.30 EPS past 5Y16.40% ROI12.90% 52W High-12.56% Beta0.90
Dividend %- Quick Ratio0.60 Sales past 5Y16.80% Gross Margin8.60% 52W Low8.55% ATR1.40
Employees25600 Current Ratio0.80 Sales Q/Q-5.00% Oper. Margin5.10% RSI (14)55.26 Volatility2.01% 2.14%
OptionableYes Debt/Eq0.96 EPS Q/Q106.40% Profit Margin3.40% Rel Volume0.66 Prev Close69.23
ShortableYes LT Debt/Eq0.91 EarningsFeb 14 AMC Payout0.00% Avg Volume4.10M Price69.97
Recom2.60 SMA201.68% SMA50-0.28% SMA200-4.10% Volume2,716,030 Change1.07%
Nov-04-16Upgrade Deutsche Bank Sell → Hold $69 → $70
Aug-02-16Reiterated Mizuho Neutral $77 → $82
Jun-20-16Downgrade Morgan Stanley Equal-Weight → Underweight
Jun-16-16Initiated Bernstein Underperform
Jun-07-16Resumed BofA/Merrill Neutral
Apr-27-16Reiterated FBR Capital Mkt Perform $90 → $75
Mar-16-16Initiated Credit Suisse Outperform
Mar-01-16Downgrade Mizuho Buy → Neutral $77
Feb-22-16Downgrade Deutsche Bank Hold → Sell $93 → $61
Feb-18-16Reiterated Barclays Overweight $102 → $85
Feb-17-16Reiterated Maxim Group Buy $109 → $95
Jan-21-16Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-19-16Downgrade Leerink Partners Outperform → Mkt Perform
Jan-13-16Reiterated Mizuho Buy $101 → $93
Oct-05-15Reiterated Leerink Partners Outperform $105 → $95
Jul-30-15Reiterated RBC Capital Mkts Outperform $87 → $96
Jul-16-15Initiated Mizuho Buy $98 → $101
Jun-18-15Initiated Oppenheimer Perform
Jun-01-15Downgrade Raymond James Outperform → Mkt Perform
May-20-15Initiated Robert W. Baird Neutral $94
Feb-18-17 01:04PM  EXPRESS SCRIPTS HOLDING CO. Financials
01:24AM  [$$] Merger's Collapse Could Boost Anthem Stock at
Feb-17-17 09:30AM  The Zacks Analyst Blog Highlights: Merck, PNC Financial, Express Scripts, VeriSign and Martin Marietta
09:26AM  Express Scripts Holding Co. :ESRX-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17, 2017
Feb-16-17 04:11PM  Express Scripts Named one of Fortune Magazine's World's Most Admired Companies of 2017 PR Newswire
01:50PM  Q4 Earnings Season Scorecard & Top Analyst Reports
01:43PM  We dug into the drug company Martin Shkreli sold out to the feds, and man is it ugly
10:10AM  Company News for February 16, 2017
08:53AM  Masimo Gets CE Mark for RRp on MightySat Rx Pulse Oximeter
Feb-15-17 03:31PM  Edited Transcript of ESRX earnings conference call or presentation 15-Feb-17 1:30pm GMT
12:02PM  Express Scripts: Rx For Earnings Growth
11:06AM  Express Scripts Officials Use Earnings Call to Blame Pharma for Drug Pricing
09:01AM  Express Scripts (ESRX) Earnings Top, Revenues Lag in Q4
08:30AM  Express Scripts Holding Co Earnings Call scheduled for 8:30 am ET today
08:05AM  Early movers: PEP, ANTM, HLT, AMZN, GOOGL, IART & more at CNBC
Feb-14-17 07:25PM  Express Scripts Posts $5.39 Per Diluted Share Ahead of Feb. 15 Earnings Call
04:49PM  [$$] Express Scripts Revenue Falls at The Wall Street Journal
04:23PM  Express Scripts beats 4Q profit forecasts
04:19PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
04:13PM  Better Buy: CVS Health Corporation vs. Express Scripts at Motley Fool
04:03PM  Express Scripts EPS beats, revenues miss
04:01PM  Express Scripts Announces 2016 Fourth Quarter and Full Year Results PR Newswire
12:12PM  Today's charts: Lending Club, Express Scripts, AIG earnings on tap
11:45AM  Headline Risk Haunts PBMs As Drug Pricing Debate Intensifies
07:07AM  Q4 2016 Express Scripts Holding Co Earnings Release - After Market Close
Feb-13-17 09:45AM  Top 5 Earnings to Look For on Tuesday
08:57AM  Healthcare Stock Q4 Earnings Slated for Feb 14: ESRX, CRL, Q
Feb-09-17 05:32PM  WellDyneRx, LLC -- Moody's affirms WellDyneRx's first lien bank rating at B3; Caa1 CFR at Moody's
12:26PM  CVS defends PBM industry against drug price hikes
11:14AM  Don't Panic: Gilead Sciences Really Isn't a Value Trap at Motley Fool
Feb-08-17 09:13AM  Express Scripts (ESRX) Q4 Earnings: What's in the Cards?
Feb-07-17 08:55AM  Affordable Obamacare alternative possible, Express Scripts CEO says at
Feb-06-17 11:41AM  Express Scripts: Prescription Drug Spending Fell in 2016 at Investopedia
11:33AM  One of the largest middlemen in the pharma industry just shed a little light on the murky world of drug pricing
08:46AM  CEO of the biggest US benefits manager sees an affordable Obamacare replacement as possible at CNBC
07:40AM  Express Scripts CEO: Transparency will bring drug prices ...
07:36AM  Express Scripts CEO: Negotiating lower drug pricing
07:32AM  Express Scripts says prescription drug spending slowed in 2016
06:00AM  Express Scripts Fights Back Against Irresponsible Drug Pricing; Holds U.S. Drug Spending Increase to 3.8 Percent in 2016 PR Newswire
12:01AM  Drug prices rose 11 percent last year, providing fuel for both sides of price debate at CNBC
Jan-28-17 11:25PM  Stocks Reach Their 3-Year Low Prices
Jan-27-17 06:47PM  Express Scripts shares dip after Citron Research compares company to NYC crime boss at CNBC
05:12PM  Express Scripts Falls on Attack From Andrew Left
Jan-26-17 06:00PM  WD Wolverine Holdings, LLC -- Moody's downgrades WD Wolverine's CFR to Caa1 at Moody's
03:17PM  Weitz Funds Comments on Express Scripts
11:10AM  [$$] Walgreens-Rite Aid Deal Still in FTC Review at The Wall Street Journal
Jan-25-17 07:03PM  Cramer: It's not too late to get into the market
02:28PM  Could Pharmacy Benefit Managers Be Trump's Next Target?
Jan-24-17 03:13PM  3 Stocks Dominating the Future of Healthcare at Motley Fool
Jan-23-17 04:24PM  Aetna May Not Be Ready to Scrap Its Scuttled $37 Billion Humana Tie-up
Jan-18-17 11:12AM  Express Scripts Holding Company Announces Fourth Quarter and Full Year 2016 Earnings Conference Call GlobeNewswire
Jan-12-17 04:00PM  Insulin Drug Offers Hope for MannKind
Jan-11-17 07:24AM  Express Scripts Holding Co. breached its 50 day moving average in a Bullish Manner : ESRX-US : January 11, 2017
Jan-10-17 04:22PM  Mylan CEO: Trump a very business-minded, solution-oriente...
04:17PM  Mylan CEO: EpiPen started a much-needed conversation in h...
02:14PM  Express Scripts CEO: Many drug list prices are still too ...
Jan-06-17 12:00AM  Cheating Death Can Cost $200,000 as Cancer Tops Pharma Sales at Bloomberg
12:00AM  Cheating Death Can Cost $200,000 as Cancer Leads Sales
Jan-05-17 03:15PM  Newest CareSource exec to oversee pharmaceuticals at
Jan-04-17 11:43AM  Express Scripts Holding Company to Present at the J.P. Morgan Healthcare Conference PR Newswire
Jan-02-17 10:13AM  A Sampling Of Citron's Most Influential Tweets
Dec-21-16 08:57AM  Bob Doll's top 5 stocks for 2017
Dec-20-16 03:05PM  Why Healthcare and Trade Stocks Tempered Moat Index Upside
Dec-19-16 03:30PM  Year In Review 2016: Leadership changes at Express Scripts, Centene expansion headline health care at
01:05PM  Factors behind Horizon Pharmas Volatility in December
Dec-18-16 12:12PM  [$$] US charges 200 times UK price for common worm pill at Financial Times
Dec-16-16 04:52PM  Mylan launching generic EpiPen
04:30PM  Express Scripts board adds 65 million shares to buyback program at MarketWatch
04:02PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Other Events
10:06AM  Express Scripts Not Worried About A Trump Presidency
09:30AM  The Zacks Analyst Blog Highlights: FedEx, Express Scripts, Mondelez, Lockheed Martin and Medtronic
Dec-15-16 01:03PM  Top Research Reports for FedEx, Mondolez & Express Scripts
09:35AM  Selloff In Express Scripts Surprising To Barclays
Dec-14-16 04:22PM  DOJ Charges Pharma Execs With Price-Fixing; Teva, Mylan Stocks Fall
04:02PM  Dow Snaps Seven-Day Win Streak After Fed Ups Expected 2017 Rate Hikes
02:51PM  Express Scripts Guidance Fails to Thrill Wall Street at TheStreet
10:49AM  Why Express Scripts Is Getting Crushed? at
10:48AM  Express Scripts Shares Plummet Despite Few Concerns on Trump Presidency
10:30AM  Express Scripts' stock turns sharply lower; CEO says drug pricing debate 'is not going away' at MarketWatch
10:25AM  Express Scripts sees no let up in drug pricing chatter Reuters
09:35AM  CVS Health Corporation's Biggest Mistake in 2016 at Motley Fool
08:09AM  Eli Lilly (LLY) to Offer Discount on Insulin from January
07:45AM  Early movers: JOY, ESRX, NVDA, FOXA, WFC, HTZ & more at CNBC
07:36AM  Stock Futures Pause as Fed Looks Set to Raise Rates
07:20AM  Express Scripts stock gains after profit outlook at MarketWatch
07:18AM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
07:00AM  Express Scripts Holding Company Announces 2017 Financial Guidance PR Newswire
Dec-13-16 08:04PM  New diabetes guidelines imminent, Jardiance sales may surge
05:14PM  Express Scripts to Include Harvoni in Hepatitis Cure Value Program
12:38PM  Fichthorn's latest shorts: AN, KMX & more
09:53AM  Eli Lilly and Express Scripts Announce Program to Lower Insulin Prices to Avoid Mylan-Like Uproar
08:22AM  [$$] Eli Lilly Offers Discount for Insulin at The Wall Street Journal
06:30AM  Lilly Announces Program to Provide Insulin at Discounted Prices PR Newswire
Dec-12-16 10:15AM  Express Scripts Holding Co. Value Analysis (NASDAQ:ESRX) : December 12, 2016
07:00AM  Express Scripts Announces Enhancements to Industry Leading SafeGuardRx(SM) Programs PR Newswire
Dec-09-16 12:55PM  Shortseller's Tweet Burns Express Scripts at Investopedia
11:34AM  Citron's Left Calls Express Scripts Drug Price Culprit
11:34AM  Citron's Left Calls Express Scripts Drug Price Culprit at Bloomberg
10:39AM  Analysts Skeptical of Andrew Left's Express Scripts Criticism
07:44AM  Express Scripts Holding Co. breached its 50 day moving average in a Bearish Manner : ESRX-US : December 9, 2016
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States, Canada, and Europe. It operates in two segments, PBM and Other Business Operations. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; and Express Scripts SafeGuardRxSM, a suite of solutions targeting the medication classes that pose a budgetary threat to its clients. The Other Business Operations segment distributes pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides consulting services, such as design, implementation, and project management for pharmaceutical and biotechnology manufacturers to collect scientific evidence to guide the use of medicines. The company serves care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2016, it operated four automated dispensing home delivery pharmacies; one non-automated dispensing home delivery pharmacy; and one non-dispensing home delivery pharmacy, as well as various non-dispensing order processing and patient contact centers, specialty drug pharmacies, and fertility pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Neville EverettSr. VP, Sup. Chain & SpecialtyJan 03Sale69.411,12377,94712,712Jan 05 04:01 PM
Miller Steven BSr. VP & Chief Med. OfficerNov 09Option Exercise49.5021,7981,078,89256,615Nov 14 04:02 PM
Miller Steven BSr. VP & Chief Med. OfficerNov 09Sale75.0221,7981,635,35134,817Nov 14 04:02 PM
Anderson Phyllis S.Sr. VP & Ch. Marketing OfficerNov 09Sale74.7464247,9838,173Nov 14 04:01 PM
MYERS WOODROW A JRDirectorSep 14Option Exercise56.0312,036674,35125,788Sep 16 04:47 PM
MYERS WOODROW A JRDirectorSep 14Sale70.4012,036847,38313,752Sep 16 04:47 PM
McGinnis Christopher AVP, Controller & Ch. Acct. OffSep 12Sale70.771,785126,3243,170Sep 13 04:51 PM
Mergenthaler FrankDirectorMay 27Option Exercise30.834,748146,38126,677May 31 04:04 PM
Neville EverettSenior VP, Supply ChainMay 10Sale74.1180059,28813,835May 11 04:01 PM
MAC MAHON THOMAS PDirectorApr 29Option Exercise30.8313,128404,73655,689May 03 04:06 PM
MAC MAHON THOMAS PDirectorApr 29Sale73.935,482405,30150,207May 03 04:06 PM
McGinnis Christopher AVP, Controller & Ch. Acct. OffMar 10Sale68.5657939,6955,929Mar 11 04:27 PM
Anderson Phyllis S.Sr. VP & Ch. Marketing OfficerMar 07Sale71.1461443,6814,346Mar 09 04:01 PM
Mergenthaler FrankDirectorMar 02Option Exercise22.8710,954250,51824,075Mar 04 04:19 PM
STERNBERG SEYMOURDirectorMar 02Sale71.478,400600,34931,062Mar 03 04:03 PM
Houston ChristineSenior VP, OperationsMar 01Option Exercise22.8715,002343,09650,678Mar 03 04:01 PM
Houston ChristineSenior VP, OperationsMar 01Sale71.558,721623,94441,957Mar 03 04:01 PM